ArticleJournal of microbiology and biotechnology2026
Upcycling Fermented Adlay Bran Ethanol Extract Residues Promotes Human Dermal Fibroblast Proliferation and Wound Healing.
Article in Journal of microbiology and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Wound healing, critical for skin recovery after surgery, trauma, and chronic damage, proceeds through inflammation, proliferation, and remodeling phases. In this study, we focused on the proliferative phase using fermentation extracts from the residuals of Adlay bran ethanol extraction and their solvent fractions. Among them, the butanol fraction exhibited the strongest antioxidant activity and significantly enhanced the proliferation of human dermal fibroblasts, as confirmed by a real-time wound closure assay. Cell cycle analysis revealed an increased proportion of cells in the S-phase and upregulation of Cyclin A1 and Cyclin B2 mRNA, indicating accelerated progression toward the G2/M phase. We then purified the butanol fraction using C18 MPLC and HPLC and identified uridine and deoxythymidine as the main components by LC-MS/MS and NMR analysis. These nucleosides derived from fermented adlay bran residues directly promote fibroblast proliferation, highlighting their potential as sustainable bioactive compounds for skin regeneration and functional ingredient development.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.